Last reviewed · How we verify
NCT06813677: INNHEALTH
Innsbruck Health Promotion Program
NA trial testing In-person health promotion in Assessment of Vascular Health Risk Factors in 1,000 participants. Currently enrolling.
31 January 2027
Quick facts
| Lead sponsor | VASCage GmbH |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 1,000 |
| Start date | 1 May 2025 |
| Primary completion | 31 January 2027 |
| Estimated completion | 31 March 2027 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- In-person health promotion
Conditions studied
- Assessment of Vascular Health Risk Factors — all drugs for Assessment of Vascular Health Risk Factors →
Sponsor
VASCage GmbH
Who can join
18 and older, any sex, with Assessment of Vascular Health Risk Factors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary goal of this single-centre. single-arm, unblinded, pre-post interventional study is to evaluate whether a one-time health assessment and intervention affects the overall vascular health evaluated through the Life's Essential 8 overall vascular health score. Secondary goals of this study are, among others: * to describe incidence and prevalence of vascular risk-factors and behaviours * to explore prevalence and associations of health and disease in the general population with special focus on cardiovascular risk, cardiovascular diseases, markers of vascular health, signs and (prodromal) symptoms of neurodegeneration as well as psychosocial factors * to explore the prevalence of hearing disorders in the general population * to collect voice and speech samples to identify novel biomarkers that correlate to vascular health and/or hearing status
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06813677
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other VASCage GmbH trials
Trials by the same sponsor.
- NCT07511868 — Digital Application for Stroke Health · NA · not yet recruiting
- NCT06940635 — Exploratory Study on the Potential Cross-System Effects of BCI-FES Hand Therapy on Dysphagia and Aphasia in Chronic Stro · NA · recruiting
- NCT05741827 — YOUhealTH - a Study to Improve Cardiovascular Health in Adolescents and Adults · NA · completed
- NCT04749004 — A Randomized-Controlled Lifestyle Intervention to Increase Physical Activity Levels in Adolescents · NA · completed
- NCT04845269 — Post-Stroke Osteopathy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06813677 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by VASCage GmbH
- Last refreshed: 19 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06813677.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing